IHH Healthcare Berhad (IHH) Stock Overview
An investment holding company, provides healthcare services in Singapore, Malaysia, India, Greater China, Japan, Türkiye and Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
IHH Community Fair Values
Create NarrativeSee what 12 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
IHH Healthcare Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 8.69 |
| 52 Week High | RM 10.48 |
| 52 Week Low | RM 6.42 |
| Beta | 0.13 |
| 1 Month Change | -3.87% |
| 3 Month Change | -2.69% |
| 1 Year Change | 25.76% |
| 3 Year Change | 46.79% |
| 5 Year Change | 50.87% |
| Change since IPO | 181.23% |
Recent News & Updates
Narrative Update • Jun 01
IHH: Higher Growth And Richer P/E Assumptions Will Support Bullish Outlook
Analysts have adjusted their fair value estimate for IHH Healthcare Berhad from MYR9.86 to MYR10.13 as they recalibrate assumptions around revenue growth, profit margins, discount rate and future P/E levels, leading to a modestly higher price target. What's in the News IHH Healthcare Berhad reported property, plant and equipment written off of MYR 1 million for the first quarter ended March 31, 2026, consistent with the MYR 1 million reported a year earlier (Key Developments).Analysis Article • May 28
IHH Healthcare Berhad Just Missed EPS By 8.6%: Here's What Analysts Think Will Happen Next
IHH Healthcare Berhad ( KLSE:IHH ) just released its latest first-quarter report and things are not looking great...Recent updates
Narrative Update • Jun 01
IHH: Higher Growth And Richer P/E Assumptions Will Support Bullish Outlook
Analysts have adjusted their fair value estimate for IHH Healthcare Berhad from MYR9.86 to MYR10.13 as they recalibrate assumptions around revenue growth, profit margins, discount rate and future P/E levels, leading to a modestly higher price target. What's in the News IHH Healthcare Berhad reported property, plant and equipment written off of MYR 1 million for the first quarter ended March 31, 2026, consistent with the MYR 1 million reported a year earlier (Key Developments).Analysis Article • May 28
IHH Healthcare Berhad Just Missed EPS By 8.6%: Here's What Analysts Think Will Happen Next
IHH Healthcare Berhad ( KLSE:IHH ) just released its latest first-quarter report and things are not looking great...Narrative Update • Apr 21
IHH: Refined Margin And P/E Assumptions Will Support More Upbeat Outlook
Narrative Update on IHH Healthcare Berhad The analyst price target for IHH Healthcare Berhad has been adjusted slightly higher to around MYR9.86 from roughly MYR9.81. Analysts attribute this change to refined assumptions on fair value, profit margins and future P/E that offset small changes in revenue growth expectations.Narrative Update • Apr 05
IHH: Updated Revenue And Margin Assumptions Will Shape Balanced Future Outlook
Analysts have adjusted their price target for IHH Healthcare Berhad slightly higher to MYR9.81 from MYR9.58, reflecting updated assumptions around revenue growth, profit margins and the future P/E multiple used in their valuation work. Valuation Changes Fair Value: Adjusted from MYR9.58 to MYR9.81, reflecting a small upward change in the modelled intrinsic value per share.Narrative Update • Mar 22
IHH: Updated Growth And Margin Assumptions Will Support Balanced Future Outlook
Analysts have raised their price target for IHH Healthcare Berhad from MYR9.46 to MYR9.58, citing updated assumptions on revenue growth, profit margins, and a slightly lower future P/E multiple. Valuation Changes Fair Value: Revised slightly higher from MYR9.46 to MYR9.58 per share.Narrative Update • Mar 06
IHH: Incentive Plan And Refined Assumptions Will Support Balanced Outlook
Analysts now place their price target for IHH Healthcare Berhad at MYR9.46, up from MYR8.99, reflecting updated assumptions around revenue growth, profit margins and a slightly lower projected future P/E multiple. What's in the News IHH Healthcare Berhad has scheduled a Special and Extraordinary Shareholders Meeting for January 20, 2026, at 14:00 Singapore Standard Time in Kuala Lumpur, Malaysia (Key Developments).Narrative Update • Feb 20
IHH: Incentive Plan And Refined Assumptions Will Support Balanced Outlook
Analysts have slightly lifted their fair value estimate for IHH Healthcare Berhad from MYR8.89 to MYR8.99, citing updated assumptions around revenue growth, profit margins, and a modestly higher future P/E multiple. What's in the News IHH Healthcare Berhad has scheduled a Special or Extraordinary Shareholders Meeting for Jan 20, 2026, at 14:00 Singapore Standard Time in Kuala Lumpur, Malaysia (Key Developments).Analysis Article • Feb 16
Is IHH Healthcare Berhad (KLSE:IHH) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Narrative Update • Feb 06
IHH: Incentive Plan And Modest Assumption Tweaks Will Support Balanced Outlook
Analysts have nudged their fair value estimate for IHH Healthcare Berhad slightly higher to RM8.89 from RM8.87, reflecting updated assumptions on the discount rate, revenue growth, profit margins and future P/E. What's in the News IHH Healthcare Berhad has scheduled a Special or Extraordinary Shareholders Meeting for Jan 20, 2026, at 14:00 Singapore Standard Time in Kuala Lumpur, Malaysia (Key Developments).Narrative Update • Jan 23
IHH: Updated Incentive Plan And Steady Assumptions Will Shape Balanced Outlook
Analysts have nudged their price target for IHH Healthcare Berhad slightly higher to reflect updated views on fair value, revenue growth, profit margins and future P/E assumptions, resulting in a modest uplift from the previous target to RM8.87. What's in the News A special or extraordinary shareholders meeting is scheduled for January 20, 2026, at 14:00 Singapore Standard Time in Kuala Lumpur to address key incentive matters for IHH Healthcare Berhad.Analysis Article • Jan 12
Investor Optimism Abounds IHH Healthcare Berhad (KLSE:IHH) But Growth Is Lacking
When close to half the companies in Malaysia have price-to-earnings ratios (or "P/E's") below 14x, you may consider IHH...Narrative Update • Jan 08
IHH: Stable Assumptions And Upcoming Meeting Will Support Balanced Outlook
Analysts have kept their price target for IHH Healthcare Berhad unchanged at RM8.86. This reflects consistent assumptions around discount rate, revenue growth, profit margin and future P/E that continue to underpin their valuation view.Analysis Article • Dec 24
Estimating The Intrinsic Value Of IHH Healthcare Berhad (KLSE:IHH)
Key Insights IHH Healthcare Berhad's estimated fair value is RM9.01 based on 2 Stage Free Cash Flow to Equity Current...Narrative Update • Dec 16
IHH: Future Margins And Payout Will Continue To Support Balanced Outlook
Narrative Update on IHH Healthcare Berhad Analysts have marginally trimmed their price target on IHH Healthcare Berhad by about RM0.01, reflecting fine tuned expectations around long term revenue growth, profit margins, and valuation multiples, while maintaining an overall stable outlook on the business. What's in the News A special and extraordinary shareholders meeting is scheduled for January 20, 2026, at 14:00 Singapore Standard Time in Kuala Lumpur to consider key corporate matters and shareholder resolutions (company event notice).Narrative Update • Dec 01
IHH: Future Margins And Payout Will Sustain A Balanced Outlook
Analysts have raised their price target for IHH Healthcare Berhad from RM8.53 to RM8.86, citing modest improvements in fair value estimates and profit margins, despite slightly lower revenue growth assumptions. Valuation Changes The Fair Value Estimate has increased slightly from MYR8.53 to MYR8.86 per share.Analysis Article • Nov 18
IHH Healthcare Berhad's (KLSE:IHH) Returns On Capital Are Heading Higher
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...Narrative Update • Nov 17
IHH: Dividend Payout And Stable Outlook Will Balance Future Margins
Analyst Price Target Update for IHH Healthcare Berhad Analysts have raised their price target for IHH Healthcare Berhad slightly from RM8.52 to RM8.53, citing small upward adjustments in profit margin forecasts. This comes despite marginally lower expectations for revenue growth and future price-to-earnings ratios.Narrative Update • Nov 03
IHH: Dividend Payments And Profit Margins Will Influence Healthcare Sector Outlook
Analysts have raised their price target for IHH Healthcare Berhad slightly, from RM8.45 to RM8.52. This reflects modest adjustments in their fair value assessments and expectations for profitability.Analysis Article • Oct 31
IHH Healthcare Berhad (KLSE:IHH) Has A Somewhat Strained Balance Sheet
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Narrative Update • Oct 20
Ambulatory And Digital Integration Will Shape Singapore And Malaysia Healthcare
Analysts have slightly raised their price target for IHH Healthcare Berhad from RM8.42 to RM8.45, citing continued confidence in the company's financial metrics and stability. What's in the News IHH Healthcare Berhad announced an interim single tier cash dividend of RMB 0.050 per ordinary share for the financial year ending 31 December 2025 (Key Developments).Narrative Update • Oct 06
Ambulatory And Digital Integration Will Shape Singapore And Malaysia Healthcare
Analysts have raised their price target for IHH Healthcare Berhad from RM8.24 to RM8.42, with modest improvements in revenue growth forecasts cited as the primary driver for the adjustment. What's in the News IHH Healthcare Berhad has announced an interim single tier cash dividend of RMB 0.050 per ordinary share for the financial year ending 31 December 2025 (Key Developments).Analysis Article • Sep 25
IHH Healthcare Berhad (KLSE:IHH) Is Due To Pay A Dividend Of MYR0.05
IHH Healthcare Berhad ( KLSE:IHH ) has announced that it will pay a dividend of MYR0.05 per share on the 30th of...Analysis Article • Sep 18
IHH Healthcare Berhad's (KLSE:IHH) Share Price Could Signal Some Risk
IHH Healthcare Berhad's ( KLSE:IHH ) price-to-earnings (or "P/E") ratio of 29.1x might make it look like a strong sell...Analysis Article • Sep 01
IHH Healthcare Berhad (KLSE:IHH) Is Due To Pay A Dividend Of MYR0.05
IHH Healthcare Berhad ( KLSE:IHH ) will pay a dividend of MYR0.05 on the 30th of October. The payment will take the...Analysis Article • Aug 04
IHH Healthcare Berhad (KLSE:IHH) Shares Could Be 49% Below Their Intrinsic Value Estimate
Key Insights IHH Healthcare Berhad's estimated fair value is RM13.21 based on 2 Stage Free Cash Flow to Equity IHH...Analysis Article • Jul 17
IHH Healthcare Berhad (KLSE:IHH) Shareholders Will Want The ROCE Trajectory To Continue
There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...
New Narrative • Dec 01
Healing Horizons Expansion Fuels Profit Surge Amid Renovation Resilience
Strategic acquisitions and expansions, including Island Hospital and Fortis Hospital, are poised to enhance revenue through increased patient volume and diversified services.Shareholder Returns
| IHH | MY Healthcare | MY Market | |
|---|---|---|---|
| 7D | 1.0% | -0.5% | -1.2% |
| 1Y | 25.8% | 22.8% | 9.5% |
Return vs Industry: IHH exceeded the MY Healthcare industry which returned 22.8% over the past year.
Return vs Market: IHH exceeded the MY Market which returned 9.5% over the past year.
Price Volatility
| IHH volatility | |
|---|---|
| IHH Average Weekly Movement | 2.8% |
| Healthcare Industry Average Movement | 5.1% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in MY Market | 11.9% |
| 10% least volatile stocks in MY Market | 2.7% |
Stable Share Price: IHH has not had significant price volatility in the past 3 months compared to the MY market.
Volatility Over Time: IHH's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 76,000 | Prem Kumar Nair | www.ihhhealthcare.com |
IHH Healthcare Berhad, an investment holding company, provides healthcare services in Singapore, Malaysia, India, Greater China, Japan, Türkiye and Europe, and internationally. The company offers primary care services, such as outpatient treatment, check-ups, vaccinations, preventive care, and patient education services; secondary and tertiary care services, including medical emergencies and acute treatment, diagnostics and lab services; quaternary services comprising specialist consultative care, advanced treatment, complex surgery, and inpatient care services; and quaternary care services, such as organ transplants, neurosurgery, cardiac surgery, and reconstructive plastic surgery; and complementary ancillary services. It also engages in the provision of catering, laundry, and cleaning services for hospitals, as well as services of preparation and serving food; supervise and manage the construction of healthcare facilities; conduct research, develop, and market healthcare information systems, web-based applications, and other technology solutions; e-consulting and marketplace activities relating to all health-related products; import and wholesale of drug and medical materials; and operates pharmacy.
IHH Healthcare Berhad Fundamentals Summary
| IHH fundamental statistics | |
|---|---|
| Market cap | RM 77.58b |
| Earnings (TTM) | RM 2.12b |
| Revenue (TTM) | RM 26.00b |
36.3x
P/E Ratio3.0x
P/S RatioIs IHH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IHH income statement (TTM) | |
|---|---|
| Revenue | RM 26.00b |
| Cost of Revenue | RM 17.37b |
| Gross Profit | RM 8.64b |
| Other Expenses | RM 6.52b |
| Earnings | RM 2.12b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.24 |
| Gross Margin | 33.21% |
| Net Profit Margin | 8.13% |
| Debt/Equity Ratio | 39.1% |
How did IHH perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yield44%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/15 13:41 |
| End of Day Share Price | 2026/06/15 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
IHH Healthcare Berhad is covered by 30 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ken-Wern Lim | Affin Hwang Investment Bank |
| Khir Goh | AmInvestment Bank Berhad |
| Laura Emmet Carney | Bernstein |